Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
Título
Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
Autor
Lucie Hénaut, Aurélien Mary, Michel Brazier, Jean-Philippe Lanoix, Jean-Luc Schmit
Fecha
2020
Materia
Azithromycin, type I interferon, hydroxychloroquine, SARS-CoV-2, COVID-19
Identificador
DOI: 10.3389/fpubh.2020.00185
Fuente
Frontiers in Public Health
Editor
Frontiers Media S.A.
Cobertura
Public aspects of medicine
Archivos
Colección
Citación
Lucie Hénaut, Aurélien Mary, Michel Brazier, Jean-Philippe Lanoix, Jean-Luc Schmit, “Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?,” SOCICT Open, consulta 19 de abril de 2026, https://www.socictopen.socict.org/items/show/2573.
Position: 15140 (20 views)